Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Risk Determination for Chest Pain

Clinical Assessment Components

  • The American College of Cardiology recommends that risk stratification for chest pain is determined through a structured clinical assessment combining patient history, ECG findings, cardiac biomarkers, and validated risk scores, with patients categorized as low-risk, intermediate-risk, or high-risk based on these integrated findings 1, 2, 3
  • The American Heart Association suggests that anginal features that increase risk include retrosternal discomfort described as pressure, heaviness, tightness, or squeezing, and pain that gradually builds over minutes, with a specificity of 96% and LR 3.1 2, 4, 5
  • The European Society of Cardiology states that accompanying symptoms such as sweating, nausea, vomiting, shortness of breath, and fatigue should all be considered anginal equivalents and increase risk, with a specificity of 91% and LR 3.6 1, 2, 6

Objective Testing

  • The American College of Cardiology recommends that a 12-lead ECG should be obtained within 10 minutes of arrival, with high-risk findings including ST-segment elevation and ST-segment depression, with a specificity of 95% and LR 5.3 6, 8
  • The American Heart Association suggests that high-sensitivity cardiac troponins are the preferred standard, with timing for serial measurements at 1-3 hours after initial sample, and a single measurement strategy for patients with symptoms present ≥3 hours before arrival 6, 3, 9

Risk Stratification Categories

  • The American College of Cardiology recommends that low-risk patients can be designated using validated approaches such as the HEART Pathway, TIMI score, and EDACS, with a risk of <1% 30-day MACE 3, 9
  • The American Heart Association states that intermediate-risk patients have a 1-10% risk of 30-day MACE and benefit most from cardiac imaging and testing, with initial assessment using transthoracic echocardiography 6, 3, 9
  • The European Society of Cardiology suggests that high-risk patients require immediate intervention, with features including ongoing chest pain with ischemic ECG changes, elevated troponin levels, and hemodynamic instability 10, 8

Validated Risk Scores

  • The American College of Cardiology recommends that the HEART score is effective for identifying both patients safe for discharge and those requiring further care, with a high-risk range (7-10) having LR 13 and low-risk range (0-3) having LR 0.20 8, 1
  • The American Heart Association suggests that the TIMI score has a high-risk range (5-7) with LR 6.8 and low-risk range (0-1) with LR 0.31, and should be used routinely in emergency department and outpatient settings 6, 3

Special Populations

  • The American College of Cardiology recommends that ACS should be strongly considered in older patients (>75 years), as they may present with atypical symptoms including confusion, presyncope, syncope, or vague abdominal symptoms 1, 2
  • The American Heart Association states that patients with diabetes have a higher prevalence of angina with potentially lower functional capacity and may have lower incidence of obstructive CAD despite symptoms, with a specificity of 96% and LR 2.6 1, 2

REFERENCES

7

Management of Acute Chest Pain [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025